BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 17211452)

  • 1. Differences between the abilities of tegaserod and motilin receptor agonists to stimulate gastric motility in vitro.
    Jarvie EM; North Laidler VJ; Corcoran S; Bassil A; Sanger GJ
    Br J Pharmacol; 2007 Feb; 150(4):455-62. PubMed ID: 17211452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GSK962040: a small molecule, selective motilin receptor agonist, effective as a stimulant of human and rabbit gastrointestinal motility.
    Sanger GJ; Westaway SM; Barnes AA; Macpherson DT; Muir AI; Jarvie EM; Bolton VN; Cellek S; Näslund E; Hellström PM; Borman RA; Unsworth WP; Matthews KL; Lee K
    Neurogastroenterol Motil; 2009 Jun; 21(6):657-64, e30-1. PubMed ID: 19374732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The rabbit motilin receptor: molecular characterisation and pharmacology.
    Dass NB; Hill J; Muir A; Testa T; Wise A; Sanger GJ
    Br J Pharmacol; 2003 Nov; 140(5):948-54. PubMed ID: 14504130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The antibiotic azithromycin is a motilin receptor agonist in human stomach: comparison with erythromycin.
    Broad J; Sanger GJ
    Br J Pharmacol; 2013 Apr; 168(8):1859-67. PubMed ID: 23190027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RQ-00201894: A motilin receptor agonist causing long-lasting facilitation of human gastric cholinergically-mediated contractions.
    Broad J; Takahashi N; Tajimi M; Sudo M; Góralczyk A; Parampalli U; Mannur K; Yamamoto T; Sanger GJ
    J Pharmacol Sci; 2016 Feb; 130(2):60-5. PubMed ID: 26685754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 5-HT4 receptor agonist, tegaserod, is a potent 5-HT2B receptor antagonist in vitro and in vivo.
    Beattie DT; Smith JA; Marquess D; Vickery RG; Armstrong SR; Pulido-Rios T; McCullough JL; Sandlund C; Richardson C; Mai N; Humphrey PP
    Br J Pharmacol; 2004 Nov; 143(5):549-60. PubMed ID: 15466450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythromycin: a motilin agonist and gastrointestinal prokinetic agent.
    Weber FH; Richards RD; McCallum RW
    Am J Gastroenterol; 1993 Apr; 88(4):485-90. PubMed ID: 8470625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concentration-dependent stimulation of cholinergic motor nerves or smooth muscle by [Nle13]motilin in the isolated rabbit gastric antrum.
    Van Assche G; Depoortere I; Thijs T; Janssens JJ; Peeters TL
    Eur J Pharmacol; 1997 Oct; 337(2-3):267-74. PubMed ID: 9430424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of genes for the ghrelin and motilin receptors and a novel related gene in fish, and stimulation of intestinal motility in zebrafish (Danio rerio) by ghrelin and motilin.
    Olsson C; Holbrook JD; Bompadre G; Jönsson E; Hoyle CH; Sanger GJ; Holmgren S; Andrews PL
    Gen Comp Endocrinol; 2008 Jan; 155(1):217-26. PubMed ID: 17582410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-emetic and emetic effects of erythromycin in Suncus murinus: role of vagal nerve activation, gastric motility stimulation and motilin receptors.
    Javid FA; Bulmer DC; Broad J; Aziz Q; Dukes GE; Sanger GJ
    Eur J Pharmacol; 2013 Jan; 699(1-3):48-54. PubMed ID: 23201066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drugs acting at 5-HT4 , D2 , motilin, and ghrelin receptors differ markedly in how they affect neuromuscular functions in human isolated stomach.
    Broad J; Góralczyk A; Mannur K; Dukes GE; Sanger GJ
    Neurogastroenterol Motil; 2014 Jun; 26(6):851-61. PubMed ID: 24750304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro pharmacological characterization of mitemcinal (GM-611), the first acid-resistant non-peptide motilin receptor agonist, in smooth muscle of rabbit small intestine.
    Takanashi H; Yogo K; Ozaki K; Koga H; Itoh Z; Omura S
    Pharmacology; 2007; 79(3):137-48. PubMed ID: 17183187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitemcinal (GM-611), an orally active motilin receptor agonist, accelerates colonic motility and bowel movement in conscious dogs.
    Ozaki K; Sudo H; Muramatsu H; Yogo K; Kamei K; Koga H; Itoh Z; Omura S; Takanashi H
    Inflammopharmacology; 2007 Feb; 15(1):36-42. PubMed ID: 17323194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of erythromycin on gastroduodenal contractile activity in developing neonates.
    Jadcherla SR; Berseth CL
    J Pediatr Gastroenterol Nutr; 2002 Jan; 34(1):16-22. PubMed ID: 11753158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the gastroprokinetic effects of ghrelin, GHRP-6 and motilin in rats in vivo and in vitro.
    Depoortere I; De Winter B; Thijs T; De Man J; Pelckmans P; Peeters T
    Eur J Pharmacol; 2005 May; 515(1-3):160-8. PubMed ID: 15890336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An erythromycin derivative, EM-523, induces motilin-like gastrointestinal motility in dogs.
    Inatomi N; Satoh H; Maki Y; Hashimoto N; Itoh Z; Omura S
    J Pharmacol Exp Ther; 1989 Nov; 251(2):707-12. PubMed ID: 2810120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EM574, an erythromycin derivative, is a potent motilin receptor agonist in human gastric antrum.
    Satoh M; Sakai T; Sano I; Fujikura K; Koyama H; Ohshima K; Itoh Z; Omura S
    J Pharmacol Exp Ther; 1994 Oct; 271(1):574-9. PubMed ID: 7965757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The in vitro pharmacological profile of prucalopride, a novel enterokinetic compound.
    Briejer MR; Bosmans JP; Van Daele P; Jurzak M; Heylen L; Leysen JE; Prins NH; Schuurkes JA
    Eur J Pharmacol; 2001 Jun; 423(1):71-83. PubMed ID: 11438309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and in vitro effects of tegaserod, a serotonin 5-hydroxytryptamine 4 (5-HT4) receptor agonist with prokinetic activity in horses.
    Delco ML; Nieto JE; Craigmill AL; Stanley SD; Snyder JR
    Vet Ther; 2007; 8(1):77-87. PubMed ID: 17447227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of N-(3-fluorophenyl)-1-[(4-([(3S)-3-methyl-1-piperazinyl]methyl)phenyl)acetyl]-4-piperidinamine (GSK962040), the first small molecule motilin receptor agonist clinical candidate.
    Westaway SM; Brown SL; Fell SC; Johnson CN; MacPherson DT; Mitchell DJ; Myatt JW; Stanway SJ; Seal JT; Stemp G; Thompson M; Lawless K; McKay F; Muir AI; Barford JM; Cluff C; Mahmood SR; Matthews KL; Mohamed S; Smith B; Stevens AJ; Bolton VJ; Jarvie EM; Sanger GJ
    J Med Chem; 2009 Feb; 52(4):1180-9. PubMed ID: 19191554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.